-
Celltex to study mesenchymal stem cells for coronavirus treatment
pharmaceutical-technology
March 18, 2020
Celltex Therapeutics has initiated talks with the US Food and Drug Administration (FDA) to conduct a study of adult, autologous mesenchymal stem cells (MSCs) for the treatment of Covid-19 symptoms.
-
Regeneron Advances COVID-19 Development Efforts
contractpharma
March 18, 2020
Isolates hundreds of virus-neutralizing, human antibodies; will prepare manufacturing-ready cell lines so that clinical-scale production can begin immediately.
-
Xortx Therapeutics to assess XRx-101 for Covid-19 treatment
.pharmaceutical-technology
March 18, 2020
Xortx Therapeutics is set to explore XRx-101, a formulation of Oxypurinol, as a potential treatment for acute kidney and lung injury associated with Covid-19.
-
Australian researchers map immune response to Covid-19
pharmaceutical-technology
March 18, 2020
Researchers at the Peter Doherty Institute for Infection and Immunity in Australia have mapped Covid-19 immune response from an affected patient in the country.
-
Lasa & ICT explore Favipiravir therapy to fight Covid 19
expresspharma
March 18, 2020
Favipiravir is an antiviral drug and is a promising antidote for the treatment of Coronavirus disease (Covid-19).
-
Quick Look at the Anti-epidemic Monoclonal Antibodies that Target the Novel Coronavirus S Protein
PharmaSources/Xiaoyaowan
March 17, 2020
The General Office of the National Health Commission and the Office of the National Administration of Traditional Chinese Medicine of China issued the COVID-19 Diagnosis and Treatment Scheme (Trial Version 6) on Feb. 19. It's worth noting that the scheme
-
First Patient Dosed in Moderna's COVID-19 Vaccine Trial
biospace
March 17, 2020
Inside the U.S., the first clinical trial for a vaccine to the novel coronavirus that causes COVID-19 began.
-
BioNTech teams up with Fosun Pharma to test Covid-19 mRNA vaccine in China — and scores $50M investment
endpts
March 17, 2020
Having quietly launched its own mRNA vaccine efforts against the novel coronavirus to match the higher profile campaigns of Moderna and CureVac ...
-
FDA Allows New York State Department of Health Testing Authorization
americanpharmaceuticalreview
March 17, 2020
The U.S. Food and Drug Administration (FDA) took two significant actions in the agency’s ongoing and aggressive commitment to address the coronavirus outbreak (COVID19).
-
FDA Issues Emergency Use Authorization to Thermo Fisher Scientific for COVID-19 Test
americanpharmaceuticalreview
March 17, 2020
Thermo Fisher Scientific announced on March 13, 2020, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for its diagnostic test ...